Aankondiging • Mar 31
Lier Chemical Co.,LTD. to Report Q1, 2026 Results on Apr 25, 2026 Lier Chemical Co.,LTD. announced that they will report Q1, 2026 results on Apr 25, 2026 Aankondiging • Mar 28
Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026 Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026, at 14:40 China Standard Time. Location: 7F, Building 1, No. 16, Yuanyi Street, Pucheng District, Mianyang, Sichuan China Aankondiging • Dec 31
Lier Chemical Co.,LTD. to Report Fiscal Year 2025 Results on Mar 28, 2026 Lier Chemical Co.,LTD. announced that they will report fiscal year 2025 results on Mar 28, 2026 Aankondiging • Sep 30
Lier Chemical Co.,LTD. to Report Q3, 2025 Results on Oct 25, 2025 Lier Chemical Co.,LTD. announced that they will report Q3, 2025 results on Oct 25, 2025 Aankondiging • Sep 16
Lier Chemical Co.,Ltd. Approves Interim Profit Distribution Plan for 2025 Lier Chemical Co.,LTD. held its 2nd Extraordinary General Meeting of 2025 on 12 September 2025, approved cash interim dividend (tax included) of CNY 2.00000000 per 10 shares for the year 2025. Aankondiging • Aug 28
Lier Chemical Co.,LTD. Approves Board Appointments, Effective 26 August 2025 Lier Chemical Co.,LTD. at its Extraordinary General Meeting held on 26 August 2025, approved election of Wei Dejia and Meng Qin as independent directors. Aankondiging • Jul 02
Lier Chemical Co.,LTD. to Report First Half, 2025 Results on Aug 28, 2025 Lier Chemical Co.,LTD. announced that they will report first half, 2025 results on Aug 28, 2025 Aankondiging • Apr 23
Lier Chemical Co.,LTD. Approves Cash Dividend for the Year 2024 Lier Chemical Co.,LTD. approved cash dividend of CNY 2.00000000 per 10 shares (tax included) for the year 2024, at its AGM held on 18 April 2025. Aankondiging • Mar 31
Lier Chemical Co.,LTD. to Report Q1, 2025 Results on Apr 25, 2025 Lier Chemical Co.,LTD. announced that they will report Q1, 2025 results on Apr 25, 2025 Aankondiging • Mar 28
Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025 Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025, at 14:40 China Standard Time. Location: The Company's Meeting Room, Mianyang, Sichuan China Aankondiging • Dec 31
Lier Chemical Co.,LTD. to Report Fiscal Year 2024 Results on Mar 28, 2025 Lier Chemical Co.,LTD. announced that they will report fiscal year 2024 results on Mar 28, 2025 Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.049 (vs CN¥0.10 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.049 (down from CN¥0.10 in 3Q 2023). Revenue: CN¥1.86b (up 21% from 3Q 2023). Net income: CN¥39.0m (down 51% from 3Q 2023). Profit margin: 2.1% (down from 5.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Aankondiging • Sep 30
Lier Chemical Co.,LTD. to Report Q3, 2024 Results on Oct 31, 2024 Lier Chemical Co.,LTD. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥8.02, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years. Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.26 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.056 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.94b (down 4.4% from 2Q 2023). Net income: CN¥45.1m (down 78% from 2Q 2023). Profit margin: 2.3% (down from 10% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings. Aankondiging • Jun 29
Lier Chemical Co.,LTD. to Report First Half, 2024 Results on Aug 30, 2024 Lier Chemical Co.,LTD. announced that they will report first half, 2024 results on Aug 30, 2024 Reported Earnings • Apr 29
First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.34 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.34 in 1Q 2023). Revenue: CN¥1.39b (down 43% from 1Q 2023). Net income: CN¥47.8m (down 83% from 1Q 2023). Profit margin: 3.4% (down from 11% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 19% per year, which means it is performing significantly worse than earnings. Aankondiging • Mar 30
Lier Chemical Co.,LTD. to Report Q1, 2024 Results on Apr 29, 2024 Lier Chemical Co.,LTD. announced that they will report Q1, 2024 results on Apr 29, 2024 Reported Earnings • Mar 23
Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022) Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Aankondiging • Mar 23
Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024 Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024, at 14:40 China Standard Time. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥10.13, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.11 per share. Reported Earnings • Feb 01
Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022) Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Aankondiging • Dec 30
Lier Chemical Co.,LTD. to Report Fiscal Year 2023 Results on Mar 23, 2024 Lier Chemical Co.,LTD. announced that they will report fiscal year 2023 results on Mar 23, 2024 Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.60 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.60 in 3Q 2022). Revenue: CN¥1.54b (down 42% from 3Q 2022). Net income: CN¥80.3m (down 82% from 3Q 2022). Profit margin: 5.2% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.69 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.26 (down from CN¥0.69 in 2Q 2022). Revenue: CN¥2.03b (down 18% from 2Q 2022). Net income: CN¥205.0m (down 60% from 2Q 2022). Profit margin: 10% (down from 21% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 25
First quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.72 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.72 in 1Q 2022). Revenue: CN¥2.44b (down 6.5% from 1Q 2022). Net income: CN¥274.7m (down 49% from 1Q 2022). Profit margin: 11% (down from 20% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021) Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 14
Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021) Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. 3 highly experienced directors. Assistant to the General Manager and Member of Supervisory Board Fen Fang Tan is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 13
Third quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.14 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.60 (up from CN¥0.14 in 3Q 2021). Revenue: CN¥2.66b (up 138% from 3Q 2021). Net income: CN¥444.5m (up 317% from 3Q 2021). Profit margin: 17% (up from 9.5% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 09
Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.3m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jul 08
Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.2m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 42% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.30 in 1Q 2021) First quarter 2022 results: EPS: CN¥1.01 (up from CN¥0.30 in 1Q 2021). Revenue: CN¥2.61b (up 76% from 1Q 2021). Net income: CN¥534.3m (up 142% from 1Q 2021). Profit margin: 20% (up from 15% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 4.4% compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Apr 06
Upcoming dividend of CN¥0.50 per share Eligible shareholders must have bought the stock before 13 April 2022. Payment date: 13 April 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.4%). Reported Earnings • Mar 06
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 33% per year. Reported Earnings • Jan 23
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 13%, compared to a 40% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 28% per year. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥27.56, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 66% over the past three years. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.31 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.12b (up 11% from 3Q 2020). Net income: CN¥106.7m (down 34% from 3Q 2020). Profit margin: 9.5% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 15% per year. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥28.25, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years. Reported Earnings • Aug 09
Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥0.33 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.68b (up 23% from 2Q 2020). Net income: CN¥284.2m (up 65% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 27
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥30.04, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.77 per share. Reported Earnings • Apr 29
First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.16 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.48b (up 51% from 1Q 2020). Net income: CN¥220.8m (up 165% from 1Q 2020). Profit margin: 15% (up from 8.5% in 1Q 2020). The increase in margin was driven by higher revenue. Analyst Estimate Surprise Post Earnings • Mar 07
Revenue beats expectations Revenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 51% growth forecast for the Chemicals industry in China. Reported Earnings • Mar 07
Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥0.59 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥612.2m (up 97% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥25.56, the stock is trading at a trailing P/E ratio of 21.8x, down from the previous P/E ratio of 25.8x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past year are 85%. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥30.25 The company is up 33% from its price of CN¥22.71 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.22 per share. Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥27.94, the stock is trading at a trailing P/E ratio of 23.8x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past year are 123%. Is New 90 Day High Low • Jan 29
New 90-day high: CN¥25.24 The company is up 27% from its price of CN¥19.90 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.21 per share. Reported Earnings • Jan 23
Full year 2020 earnings released: EPS CN¥1.17 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥615.2m (up 98% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Analyst Estimate Surprise Post Earnings • Jan 23
Revenue beats expectations Revenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 14%, compared to a 50% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Nov 16
Market bids up stock over the past week After last week's 18% share price gain to CN¥23.71, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 109%. Reported Earnings • Oct 25
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥493.5m, up 26% from the prior year. Total revenue was CN¥4.50b over the last 12 months, up 5.2% from the prior year. Is New 90 Day High Low • Oct 05
New 90-day low: CN¥19.38 The company is down 2.0% from its price of CN¥19.85 on 07 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.15 per share.